In situ Raman spectroscopy and machine learning unveil biomolecular alterations in invasive breast cancer

Sandryne David1,2, Trang Tran1,2, Frédérick Dallaire1,2

  • 1Polytechnique Montréal, Department of Engineering Physics, Montreal, Quebec, Canada.

Abstract

Insights

Raman spectroscopy and machine learning can detect invasive breast cancer in surgical specimens with high accuracy. This technology shows promise for reducing repeat surgeries and improving outcomes for breast cancer patients.

Area of Science:

  • Biomedical Optics
  • Medical Spectroscopy
  • Computational Biology

Background:

  • Breast-conserving surgery is common for early-stage breast cancer, but incomplete resection necessitates re-excision in 20-35% of cases.
  • Improving intraoperative cancer detection can reduce re-operation rates and enhance patient survival.

Purpose of the Study:

  • To develop a machine learning model using Raman spectroscopy for ex-vivo detection of invasive breast cancer.
  • To identify specific biomolecular spectral bands indicative of cancerous tissue.

Main Methods:

  • Raman spectroscopy was employed to analyze 238 ex-vivo breast tissue specimens from 20 patients.
  • Support vector machine models were developed and validated using receiver-operating-characteristic analysis.
  • Spectra were spatially registered with histological classifications (cancer, normal, fat).

Main Results:

  • The combined Raman spectroscopy and machine learning approach achieved 93% sensitivity and 95% specificity in distinguishing normal breast tissue from invasive ductal or lobular carcinoma.
  • The model effectively utilized two key spectral bands related to protein C-C stretching and phenylalanine.

Conclusions:

  • Raman spectroscopy is a feasible technology for detecting cancer margins in surgically resected breast specimens.
  • This technique has the potential to significantly decrease the need for repeat surgeries in breast cancer treatment.

Related Concept Videos